| | | | |

Goat Virus Proves Lethal to Mesothelioma Cells in Italian Study

ByAlex Strauss

mesothelioma cellsResearchers in Italy say a virus normally found in goats could offer a new, safer way to kill malignant mesothelioma cells and improve patient outcomes. 

The virus is caprine herpesvirus 1 (CpHV-1). It has been blamed for bouts of spontaneous abortions in goat herds. But it does not appear to cause any disease in humans. In fact, previous studies show CpHV-1 can kill several types of human cancer cells. 

The newest study of CpHV-1 was conducted at the National Cancer Institute IRCCS G. Pascale Foundation in Naples. Scientists there made two important discoveries. They found that not only can CpHV-1 kill mesothelioma cells without harming normal cells, but it might also have the potential to make chemotherapy work better. 

Mesothelioma Cells are Tenacious

Mesothelioma is a rare cancer caused by asbestos. Mesothelioma cells spread quickly, forming tumors on the membranes around organs. As tumors grow, they crowd the nearby organs. 

Mesothelioma tumors on the membrane around the lungs trigger coughing, chest pain, and shortness of breath. Mesothelioma tumors on the peritoneal membrane in the abdomen cause digestive issues, bloating, and stomach pain. Eventually, mesothelioma may spread to other tissues. 

Malignant mesothelioma is also difficult to kill. It is usually not diagnosed until it is in a late stage. In addition, mesothelioma tumors release proteins that make the microenvironment around them hostile to cancer-killing immune cells. Most standard cancer treatments do not work on mesothelioma cells. 

New approaches to mesothelioma treatment focus on killing these aggressive tumors from the inside. Immunotherapy and virotherapy fall into this category. 

Attacking Mesothelioma with Virotherapy

Virotherapy uses a virus to deliver a treatment. Sometimes, it is an altered human virus. In the case of the new Italian study, it is the goat virus CpHV-1. 

The researchers say some kinds of animal viruses offer advantages over human viruses for cancer treatment. They are less likely to be pathogenic (disease-causing) in humans. Also, human cells are not already immune to them. 

When Italian researchers exposed mesothelioma cells and normal cells from the mesothelial membrane to CpHV-1, the results were exciting. 

“We found that CpHV-1 reduced cell viability and clonogenic potential in all malignant mesothelioma cell lines without affecting non-tumor cells,” writes lead author Iris Maria Forte. 

The researchers did not detect any viral DNA inside the healthy cells after treatment. But the virus sped up the rate of apoptosis or natural cell death in mesothelioma cells. The news gets even better. 

“CpHV-1 strongly synergized with cisplatin, the drug currently used in mesothelioma chemotherapy, and this agent combination did not affect normal mesothelial cells,” writes Dr. Forte. 

Scientists will need to study CpHV-1 more to understand how it works against mesothelioma. But the Italian researchers conclude that the CpHV-1/cisplatin combination “could be a feasible strategy against mesothelioma.”

Even though many countries have banned asbestos, tens of thousands of people around the world still contract mesothelioma every year.

Source:

Forte, IM, et al, “The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach”, December 8, 2021, Viruses, https://www.mdpi.com/1999-4915/13/12/2458

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…